PUBLISHER: The Business Research Company | PRODUCT CODE: 1877501
PUBLISHER: The Business Research Company | PRODUCT CODE: 1877501
An artificial intelligence (AI)-enhanced diabetes foot ulcer monitor is an advanced medical monitoring system that leverages AI algorithms to assess and track foot health in individuals with diabetes. It utilizes intelligent data interpretation and image analysis to detect early signs of ulcer formation or existing ulcers, enabling continuous, accurate, and proactive monitoring of foot conditions.
The primary product types of AI-enhanced diabetes foot ulcer monitors include wearable devices, non-wearable devices, smart sensors, and imaging systems. Wearable devices are compact, body-mounted technologies designed to continuously monitor patients' physiological signals and health parameters. These systems employ various technologies such as machine learning, deep learning, computer vision, and others, and are used across settings including hospitals and clinics, homecare, ambulatory surgical centers, and research institutions. The end-users of these devices include healthcare professionals, patients, and research organizations, with distribution occurring through both online and offline channels.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market statistics, including artificial intelligence (AI)-enhanced diabetes foot ulcer monitor industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market share, detailed artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor industry. This artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market size has grown rapidly in recent years. It will grow from $1.44 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to increasing awareness of diabetic foot complications, rising adoption of wearable health monitoring technologies, greater emphasis on early detection and personalized care, expanding government initiatives for chronic disease management, and the strengthening of healthcare infrastructure across emerging markets.
The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market size is expected to see rapid growth in the next few years. It will grow to $3.35 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to the increasing focus on improving patient engagement and adherence, rising investment in research and development for diabetic foot ulcer diagnostics, growing adoption of predictive analytics for early detection of ulcers, increasing collaboration between healthcare providers and technology firms, and rising demand for affordable and efficient wound monitoring solutions. Major trends in the forecast period include the integration of data-driven healthcare decision support systems, advancements in cloud-based health data management, enhanced decision support tools for clinicians, innovations in biofeedback-assisted treatment devices, and progress in real-time wound assessment technologies.
The rise in healthcare expenditure is anticipated to drive the growth of the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market in the coming years. Healthcare expenditure refers to the total spending by individuals, organizations, and governments on services and initiatives aimed at preserving or improving health. This expenditure is increasing due to the growing prevalence of chronic diseases, which necessitates continuous medical care, long-term treatment, and enhanced management resources. Increased healthcare funding enables hospitals and clinics to adopt AI-enhanced diabetes foot ulcer monitoring systems that improve patient management and reduce long-term treatment costs. For example, in April 2025, the Office for National Statistics (ONS), a UK-based government agency, reported that government-funded healthcare represented the majority of the country's total healthcare spending, reaching $344 billion (£258 billion) in 2024, an increase of 2.5% in real terms compared to 2023. Thus, the rise in healthcare expenditure is fueling the growth of the AI-enhanced diabetes foot ulcer monitor market.
Leading companies in the AI-enhanced diabetes foot ulcer monitor market are focusing on securing strategic funding to accelerate product development, scale manufacturing, and expand patient accessibility. Funds refer to dedicated financial resources allocated to specific development or commercialization initiatives. For instance, in July 2024, IR-MED Inc., an Israel-based medical device company, received a $500,000 grant to support the advancement of its device for early diabetic foot ulcer detection. The funding enables IR-MED to accelerate the development and commercialization of its AI-powered DiaSafe device for diabetic foot ulcer monitoring through a 13-month program set to run in the latter half of 2025. Building on the PressureSafe platform, scheduled for launch in late 2024, the DiaSafe system integrates AI-driven data analysis with infrared sensing to detect ulcers in their early stages, even when invisible to the naked eye, particularly in patients with darker skin tones. Furthermore, the platform's AI-based decision support system evaluates bioinformation against condition-specific biomarkers to determine tissue health and identify early signs of risk.
In June 2023, Swift Medical, a Canada-based digital health technology company, entered into a strategic partnership with the American Podiatric Medical Association (APMA) to advance diabetic foot ulcer and chronic wound care through AI integration. This collaboration aims to significantly enhance patient outcomes by leveraging AI-based wound assessment technologies for more accurate diagnosis and improved treatment planning. The partnership underscores a growing trend toward the use of AI in podiatric and wound management practices. The APMA, a U.S.-based professional organization, plays a key role in supporting this initiative by promoting advanced digital health adoption in clinical wound care practices.
Major players in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market are VIRTUSA CORPORATION, Net Health Systems Inc., Amplifai Health Limited, Podimetrics Inc., Orpyx Medical Technologies Inc., Spectral AI Inc., Tetsuyu Healthcare Holdings Pte Ltd., Siren Care Inc., Calceus Health Pty Ltd., WoundVision LLC., Bluedrop Medical Inc., Moticon GmbH, eKare Inc., Sensoria Health Inc., Baliston Limited, Empo Health Inc., MolecuLight Inc., MIMOSA Diagnostics Inc., Thermology Health Ltd., IR-MED Inc., and DiabSense Private Limited.
North America was the largest region in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced diabetes foot ulcer monitor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market consists of revenues earned by entities by providing services such as image-based wound detection, wearable sensor monitoring, remote monitoring, treatment adherence tracking, and predictive healing assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market also includes sales of pressure-mapping mats, thermal imaging scanners, wound-imaging cameras, and multispectral imaging devices. values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI)-Enhanced Diabetes Foot Ulcer Monitor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence (ai)-enhanced diabetes foot ulcer monitor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced diabetes foot ulcer monitor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced diabetes foot ulcer monitor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.